Protocol for a multicentre prospective exploratory mixed-methods study investigating the modifiable psychosocial variables influencing access to and outcomes after kidney transplantation in children and young people in the UK.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 May 2024
Historique:
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 28 5 2024
Statut: epublish

Résumé

Kidney transplantation is the preferred therapy for children with stage 5 chronic kidney disease (CKD-5). However, there is a wide variation in access to kidney transplantation across the UK for children. This study aims to explore the psychosocial factors that influence access to and outcomes after kidney transplantation in children in the UK using a mixed-methods prospective longitudinal design. Qualitative data will be collected through semistructured interviews with children affected by CKD-5, their carers and paediatric renal multidisciplinary team. Recruitment for interviews will continue till data saturation. These interviews will inform the choice of existing validated questionnaires, which will be distributed to a larger national cohort of children with pretransplant CKD-5 (n=180) and their carers. Follow-up questionnaires will be sent at protocolised time points regardless of whether they receive a kidney transplant or not. Coexisting health data from hospital, UK renal registry and National Health Service Blood and Transplant registry records will be mapped to each questionnaire time point. An integrative analysis of the mixed qualitative and quantitative data will define psychosocial aspects of care for potential intervention to improve transplant access. Qualitative data will be analysed using thematic analysis. Quantitative data will be analysed using appropriate statistical methods to understand how these factors influence access to transplantation, as well as the distribution of psychosocial factors pretransplantation and post-transplantation. This study protocol has been reviewed by the National Institute for Health Research Academy and approved by the Wales Research Ethics Committee 4 (IRAS number 270493/ref: 20/WA/0285) and the Scotland A Research Ethics Committee (ref: 21/SS/0038). Results from this study will be disseminated across media platforms accessed by affected families, presented at conferences and published in peer-reviewed journals.

Identifiants

pubmed: 38806415
pii: bmjopen-2023-078150
doi: 10.1136/bmjopen-2023-078150
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e078150

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JSK is the National Institute for Health Research Fellowship grant recipient, which funds this study. LP reports grants from the National Institute for Health Research and Kidney Research UK. She is also the paediatric research lead for the UK Renal Registry.

Auteurs

Ji Soo Kim (JS)

Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK jisoo.kim@nhs.net.
NIHR Great Ormond Street Hospital Biomedical Research Centre, London, UK.

Jo Wray (J)

Centre for Outcomes and Experience Research in Children's Health, Illness and Disability, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Deborah Ridout (D)

Population, Policy and Practice, UCL Great Ormond Street Institute of Child Health, UCL, London, UK.

Lucy Plumb (L)

UK Renal Registry, Bristol, UK.
Population Health Sciences, University of Bristol Medical School, Bristol, UK.

Dorothea Nitsch (D)

UK Renal Registry, Bristol, UK.
Non-communicable disease epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Matthew Robb (M)

Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, UK.

Stephen D Marks (SD)

Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
NIHR Great Ormond Street Hospital Biomedical Research Centre, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH